Responses
Therapeutics
Systematic review and meta-analysis
Meta-analysis finds benefit for dual antiplatelet therapy but limitations preclude changing standard mono antiplatelet therapy approach for acute non-cardioembolic ischaemic stroke or transient ischaemic attack
Compose a Response to This Article
Other responses
No responses have been published for this article.